Loading organizations...
§ Venture Capital · Florida, NY, USA
Sheatree Capital is a venture capital firm that provides strategic capital to high-growth companies. The firm primarily focuses on evidence-based investing within public and private healthcare and life science sectors, supporting entities developing innovative drugs, medical devices, and diagnostics. Its approach involves identifying and nurturing ventures with strong potential.
The firm has been actively engaged in investment activities since at least 2016. Its establishment emerged from a recognition of significant opportunities within specialized technology and life science domains, aiming to back enterprises poised for advancement. The firm’s operational framework emphasizes a disciplined investment philosophy tailored to its target industries.
Sheatree Capital's portfolio includes promising startups and developing companies across its core investment areas. The firm aims to foster the growth of groundbreaking solutions that address critical needs in healthcare and technology. By committing resources and expertise, Sheatree Capital contributes to the success of its portfolio companies, driving innovation and value.
Sheatree Capital has 1 tracked investment across 1 company. The latest tracked deal is $60.0M Series A in Link Cell Therapies in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 15, 2025 | Link Cell Therapies | $60.0M Series A | Johnson & Johnson Innovation | Abraham Bassan, Wing Venture Capital |